191 related articles for article (PubMed ID: 37455914)
1. Identification of
Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
[TBL] [Abstract][Full Text] [Related]
2. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
4. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
Zhang Y; Tian Y
BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
[TBL] [Abstract][Full Text] [Related]
5. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
Subhi O; Schulten HJ; Bagatian N; Al-Dayini R; Karim S; Bakhashab S; Alotibi R; Al-Ahmadi A; Ata M; Elaimi A; Al-Muhayawi S; Mansouri M; Al-Ghamdi K; Hamour OA; Jamal A; Al-Maghrabi J; Al-Qahtani MH
PLoS One; 2020; 15(6):e0234566. PubMed ID: 32603365
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
[TBL] [Abstract][Full Text] [Related]
7. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
9. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.
Sur ML; Gaga R; Lazăr C; Lazea C; Aldea C; Sur D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1511-1517. PubMed ID: 33180046
[TBL] [Abstract][Full Text] [Related]
11. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
12. Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.
Yang Y; Liu J; Shi X; Wang M
Cancer Control; 2023; 30():10732748231199647. PubMed ID: 37643366
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid cancer with Hashimoto's thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression.
Kim SJ; Lee SE; Kim YI; Nam-Goong IS; Jung HW; Kim ES
Clin Exp Med; 2023 Jul; 23(3):833-840. PubMed ID: 35871446
[TBL] [Abstract][Full Text] [Related]
14. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
17. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
18. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
19. Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.
Cui L; Zhang C; Ding H; Feng D; Huang H; Lu Z; Liu B
Front Immunol; 2022; 13():821601. PubMed ID: 35720279
[TBL] [Abstract][Full Text] [Related]
20. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]